Towards Precision Medicine in Neuropathic Pain 1: Using Randomised Trial Evidence to Uncover Individual Treatment Effects

Product not yet rated

Includes a Live Web Event on 03/19/2026 at 5:00 PM (EDT)

  • Register
    • Non-member - Free!
    • Member - Free!
    • Retired - Free!
    • Trainee - Free!
    • Life Member - Free!
    • Life Honorary - Free!
    • Honorary - Free!

This webinar will take place on Thursday, 19 March at 05:00 p.m. ET

This Global Year 2026 webinar is free to all. 

Despite the promise of precision medicine, major conceptual and methodological challenges have limited our ability to reliably identify differential treatment response in neuropathic pain. This webinar will examine the conceptual foundations of precision medicine and the implications for what can, and cannot, be inferred about treatment response from randomised evidence. It will provide a high-level overview of approaches that seek to move beyond average effects, including methods for characterising heterogeneity of treatment effects in parallel-group trials and multiple-phase N-of-1 crossover designs. The webinar aims to highlight how a more explicit and principled understanding of treatment response can clarify both the possibilities and limits of precision medicine in neuropathic pain. 

Moderator:

Harrison Hansford

Speakers:

Rob Herbert - Australia

Giovanni Ferreira BPhysio (Hons), MSc, PhD 

Jennifer Gewandter, PhD, MPH 

Panelists:

Dr. Michael Ferraro, Neuroscience Research Australia.

A/Prof. Daniela M Menichella, Northwestern University.

Prof. Stefano Tamburin, University of Verona.

Giovanni Ferreira

BPhysio (Hons), MSc, PhD

Institute for Musculoskeletal Health, University of Sydney,

Giovanni is a Senior Research Fellow and National Health and Medical Research Council Emerging Leader at the Institute for Musculoskeletal Health, University of Sydney, Australia. Giovanni’s research focuses on investigating the effectiveness of pharmacological and non-pharmacological interventions, as well as new models of care, to improve outcomes for people with chronic pain. 

Prof Rob Herbert

PhD AStat FAHMS

UNSW Sydney

Rob is a physiotherapist who conducts research into the effectiveness of physiotherapy interventions, as well as muscle physiology and biomechanics. He has a long-standing interest in the design and analysis of clinical trials. He retired from full-time research in 2023 but retains honorary positions as Emeritus Professorial Fellow at NeuRA and Conjoint Professor at UNSW Sydney. He is an accredited statistician and now runs a statistical consulting business focusing on the design and analysis of randomized trials. 

Dr Jennifer Gewandter

PhD, MPH

University of Rochester

Jennifer Gewandter, PhD, MPH, is an Associate Professor at the University of Rochester, a former Associate Director of the ACTTION public-private partnership, and the PI of the University of Rochester Clinical Hub of the NIH-sponsored Early Phase Pain Investigation Clinical Network (EPPIC-Net). Her research and scholarly activities are focused on optimizing the design, conduct, and transparent dissemination of clinical trials for pain and peripheral neuropathy treatments, as well as researching interventions for painful peripheral neuropathic pain. She has been the overall PI of 2 NIH-sponsored, multi-site clinical trials and is a site PI for multiple industry-sponsored clinical trials of chronic pain. She has authored over 100 peer-reviewed publications and has served as an Associate Editor for the Clinical Journal of Pain and Co-Section Editor for Pain Medicine. She has mentored over 40 medical students, residents, postdoctoral fellows, and clinical faculty members in clinical research and scientific writing. 

Harrison Hansford (Moderator)

BSc (Hons)

Neuroscience Research Australia (NeuRA)

Harrison is a doctoral candidate at Neuroscience Research Australia (NeuRA). His PhD focuses on applying and advancing causal inference methods to strengthen the use of observational data in guiding evidencebased management of musculoskeletal conditions. He is also committed to improving research reporting and enhancing research quality across the field. 

Key:

Complete
Failed
Available
Locked
Global Year 2026 Webinar #6
03/19/2026 at 5:00 PM (EDT)  |  90 minutes
03/19/2026 at 5:00 PM (EDT)  |  90 minutes
Evaluation
8 Questions
8 Questions Please provide your feedback after which you will receive a certificate of completion.
Certificate
No credits available  |  Certificate available
No credits available  |  Certificate available